PHASE-SHIFT OF POLYSACCHARIDE CAPSULE EXPRESSION IN GROUP-B STREPTOCOCCI, TYPE-III

被引:22
作者
SELLIN, M [1 ]
HAKANSSON, S [1 ]
NORGREN, M [1 ]
机构
[1] UMEA UNIV,DEPT PEDIAT,S-90185 UMEA,SWEDEN
关键词
GROUP B STREPTOCOCCI; POLYSACCHARIDE CAPSULE; BUOYANT DENSITY; PHASE-SHIFT;
D O I
10.1006/mpat.1995.0036
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The type-specific polysaccharide capsule is an important virulence determinant in group B streptococci (GBS). The previously described inverse relationship between the buoyant density of a GBS-isolate and the capsular thickness was used to assess the frequencies of polysaccharide capsular phase-shift in clinical GBS, type III strains. Shift from intermediate density (ID) of parental strains, to high density (HD), i.e. shift from intermediate capsule thickness to poor encapsulation, was found to range from 1.2 x 10(-3) to 4.8 x 10(-6). Shift from ID to low density (LD), i.e. shift to abundant encapsulation, ranged from 1.9 x 10(-4) to 1.1 x 10(-7). Shifts were reversible in all cases, either directly (HD --> LD or vice versa) or through intermediate forms. Reversion frequencies were in some isolates as high as 10(-1). Phase-shift frequencies differed more than a thousand-fold between compared strains. Differences in phenotypic shift between strains were validated using flow cytometry. Possible modulation of capsule expression by changes in culture conditions was assessed. Variation of temperature, oxygen-tension, and presence of human serum did not affect capsule expression. However, growth at pH below 5.5 decreased the amount of capsule bound native type III polysaccharide, probably through phenotypic modification rather than genetic shift. IS861, an insertion sequence which has been proposed a regulatory function on the GBS capsule expression, was found in multiple copies in the isolates investigated. No differences in copy numberer location of IS861 between the differently encapsulated phenotypes were found.
引用
收藏
页码:401 / 415
页数:15
相关论文
共 45 条
[1]  
Baker C.J., Edwards M.S., Group B streptococcal infections, Infectious Diseases of the Fetus and Newborn Infant, pp. 742-811, (1990)
[2]  
Rubens C.J., Type III capsular polysaccharide of group B streptococci: Role in virulence and the molecular basis of capsule expression, Molecular Genetics of Bacterial Pathogenesis, pp. 327-339, (1994)
[3]  
Payne N.R., Burke B.A., Day D.L., Christenson P.D., Thompson T.R., Ferrieri P., Correlation of clinical and pathologic findings in early onset neonatal group B streptococcal infection with disease severity and prediction of outcome, Pediatr Infect Dis J, 7, pp. 836-847, (1988)
[4]  
Yeung M.K., Mattingly S.J., Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci, Infect Immun, 44, pp. 217-221, (1984)
[5]  
Rubens C.E., Wessels M.R., Heggen L.M., Dl K., Transposon mutagenesis of group B streptococcal type III capsular polysaccharide: Correlation of capsule expression with virulence, Proc Natl Acad Sci USA, 84, pp. 7208-7212, (1987)
[6]  
Wessels M.R., Rubens C.E., Benedi V.J., Kasper D.L., Definition of a bacterial virulence factor: Sialylation of the group B streptococcal capsule, Proc Natl Acad Sci USA, 86, pp. 8983-8987, (1989)
[7]  
Catlin B., Haemophilus influenzae in cultures of cerebrospinal fluid, Amer J Dis Child, 120, pp. 203-210, (1970)
[8]  
Macleod C.M., Krauss M.R., Relation to virulence of pneumococcal strains for mice to the quantity of capsular polysaccharide formed in vitro, J Exp Med, 92, pp. 1-9, (1950)
[9]  
Hakansson S., Holm S.E., Wagner M., Density profile of group B streptococci, type III, and its possible relation to enhanced virulence, J Clin Microbiol, 25, pp. 714-718, (1987)
[10]  
Hakansson S., Granlund-Edstedt M., Sellin M., Holm S.E., Demonstration and characterization of buoyant density subpopulations of group B streptococcus type III, J Infect Dis, 161, pp. 741-746, (1990)